220 related articles for article (PubMed ID: 33215566)
1. Plasminogen Deficiency and Amiloride Mitigate Angiotensin II-Induced Hypertension in Type 1 Diabetic Mice Suggesting Effects Through the Epithelial Sodium Channel.
Andersen H; Hansen MH; Buhl KB; Stæhr M; Friis UG; Enggaard C; Supramaniyam S; Lund IK; Svenningsen P; Hansen PBL; Jensen BL
J Am Heart Assoc; 2020 Dec; 9(23):e016387. PubMed ID: 33215566
[TBL] [Abstract][Full Text] [Related]
2. Significant natriuretic and antihypertensive action of the epithelial sodium channel blocker amiloride in diabetic patients with and without nephropathy.
Andersen H; Hansen PB; Bistrup C; Nielsen F; Henriksen JE; Jensen BL
J Hypertens; 2016 Aug; 34(8):1621-9. PubMed ID: 27214087
[TBL] [Abstract][Full Text] [Related]
3. Amiloride lowers blood pressure and attenuates urine plasminogen activation in patients with treatment-resistant hypertension.
Oxlund CS; Buhl KB; Jacobsen IA; Hansen MR; Gram J; Henriksen JE; Schousboe K; Tarnow L; Jensen BL
J Am Soc Hypertens; 2014 Dec; 8(12):872-81. PubMed ID: 25492830
[TBL] [Abstract][Full Text] [Related]
4. Amiloride evokes significant natriuresis and weight loss in kidney transplant recipients with and without albuminuria.
Hinrichs GR; Nielsen JR; Birn H; Bistrup C; Jensen BL
Am J Physiol Renal Physiol; 2023 Oct; 325(4):F426-F435. PubMed ID: 37560772
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)-mediated sodium retention in experimental nephrotic syndrome.
Bohnert BN; Daiminger S; Wörn M; Sure F; Staudner T; Ilyaskin AV; Batbouta F; Janessa A; Schneider JC; Essigke D; Kanse S; Haerteis S; Korbmacher C; Artunc F
Acta Physiol (Oxf); 2019 Dec; 227(4):e13286. PubMed ID: 31006168
[TBL] [Abstract][Full Text] [Related]
6. Diabetic nephropathy is associated with increased urine excretion of proteases plasmin, prostasin and urokinase and activation of amiloride-sensitive current in collecting duct cells.
Andersen H; Friis UG; Hansen PB; Svenningsen P; Henriksen JE; Jensen BL
Nephrol Dial Transplant; 2015 May; 30(5):781-9. PubMed ID: 25609736
[TBL] [Abstract][Full Text] [Related]
7. Plasmin in urine from patients with type 2 diabetes and treatment-resistant hypertension activates ENaC in vitro.
Buhl KB; Oxlund CS; Friis UG; Svenningsen P; Bistrup C; Jacobsen IA; Jensen BL
J Hypertens; 2014 Aug; 32(8):1672-7; discussion 1677. PubMed ID: 24805959
[TBL] [Abstract][Full Text] [Related]
8. Urokinase-type plasminogen activator contributes to amiloride-sensitive sodium retention in nephrotic range glomerular proteinuria in mice.
Hinrichs GR; Weyer K; Friis UG; Svenningsen P; Lund IK; Nielsen R; Mollet G; Antignac C; Bistrup C; Jensen BL; Birn H
Acta Physiol (Oxf); 2019 Dec; 227(4):e13362. PubMed ID: 31423748
[TBL] [Abstract][Full Text] [Related]
9. Urinary serine proteases and activation of ENaC in kidney--implications for physiological renal salt handling and hypertensive disorders with albuminuria.
Svenningsen P; Andersen H; Nielsen LH; Jensen BL
Pflugers Arch; 2015 Mar; 467(3):531-42. PubMed ID: 25482671
[TBL] [Abstract][Full Text] [Related]
10. Hydronephrosis is associated with elevated plasmin in urine in pediatric patients and rats and changes in NCC and γ-ENaC abundance in rat kidney.
Zachar R; Al-Mashhadi A; Dimke H; Svenningsen P; Jensen BL; Carlström M
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F547-F557. PubMed ID: 29767556
[TBL] [Abstract][Full Text] [Related]
11. Renal tubule angiotensin II type 1 receptor-associated protein promotes natriuresis and inhibits salt-sensitive blood pressure elevation.
Wakui H; Uneda K; Tamura K; Ohsawa M; Azushima K; Kobayashi R; Ohki K; Dejima T; Kanaoka T; Tsurumi-Ikeya Y; Matsuda M; Haruhara K; Nishiyama A; Yabana M; Fujikawa T; Yamashita A; Umemura S
J Am Heart Assoc; 2015 Mar; 4(3):e001594. PubMed ID: 25792129
[TBL] [Abstract][Full Text] [Related]
12. Albuminuria in kidney transplant recipients is associated with increased urinary serine proteases and activation of the epithelial sodium channel.
Hinrichs GR; Michelsen JS; Zachar R; Friis UG; Svenningsen P; Birn H; Bistrup C; Jensen BL
Am J Physiol Renal Physiol; 2018 Jul; 315(1):F151-F160. PubMed ID: 29363322
[TBL] [Abstract][Full Text] [Related]
13. Urine exosomes from healthy and hypertensive pregnancies display elevated level of α-subunit and cleaved α- and γ-subunits of the epithelial sodium channel-ENaC.
Nielsen MR; Frederiksen-Møller B; Zachar R; Jørgensen JS; Hansen MR; Ydegaard R; Svenningsen P; Buhl K; Jensen BL
Pflugers Arch; 2017 Sep; 469(9):1107-1119. PubMed ID: 28405801
[TBL] [Abstract][Full Text] [Related]
14. The acute blood pressure-lowering effect of amiloride is independent of endothelial ENaC and eNOS in humans and mice.
Ydegaard R; Andersen H; Oxlund CS; Jacobsen IA; Hansen PBL; Jürgensen JF; Peluso AA; Vanhoutte PM; Staehr M; Svenningsen P; Jensen BL
Acta Physiol (Oxf); 2019 Jan; 225(1):e13189. PubMed ID: 30240139
[TBL] [Abstract][Full Text] [Related]
15. Secretin is involved in sodium conservation through the renin-angiotensin-aldosterone system.
Bai J; Chow BK
FASEB J; 2017 Apr; 31(4):1689-1697. PubMed ID: 28082350
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of renal NaCl retention in proteinuric disease.
Svenningsen P; Friis UG; Versland JB; Buhl KB; Møller Frederiksen B; Andersen H; Zachar RM; Bistrup C; Skøtt O; Jørgensen JS; Andersen RF; Jensen BL
Acta Physiol (Oxf); 2013 Mar; 207(3):536-45. PubMed ID: 23216619
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen deficiency does not prevent sodium retention in a genetic mouse model of experimental nephrotic syndrome.
Xiao M; Bohnert BN; Aypek H; Kretz O; Grahammer F; Aukschun U; Wörn M; Janessa A; Essigke D; Daniel C; Amann K; Huber TB; Plow EF; Birkenfeld AL; Artunc F
Acta Physiol (Oxf); 2021 Jan; 231(1):e13512. PubMed ID: 32455507
[TBL] [Abstract][Full Text] [Related]
18. Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urine.
Stæhr M; Buhl KB; Andersen RF; Svenningsen P; Nielsen F; Hinrichs GR; Bistrup C; Jensen BL
Am J Physiol Renal Physiol; 2015 Aug; 309(3):F235-41. PubMed ID: 25972510
[TBL] [Abstract][Full Text] [Related]
19. Increased Epithelial Sodium Channel Activity Contributes to Hypertension Caused by Na+-HCO3- Cotransporter Electrogenic 2 Deficiency.
Wen D; Yuan Y; Warner PC; Wang B; Cornelius RJ; Wang-France J; Li H; Boettger T; Sansom SC
Hypertension; 2015 Jul; 66(1):68-74. PubMed ID: 25941340
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of long-term blood pressure control and vascular health by low-dose amiloride-based therapy in hyperaldosteronism.
Izzo JL; Hong M; Hussain T; Osmond PJ
J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1183-1190. PubMed ID: 31347775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
